Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients

QR Code

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients

Chronic myeloid leukemia (CML) patients who have BCR-ABL T315I mutation, usually present in the advance phase of the disease with overall survival (OS) shorter than those without the mutation. This study aimed to determine the prevalence of T315I mutation amongst imatinib mesylate (IM) resistant CML...

Full description

Bibliographic Details
Main Authors:	Mardziah M, Salwati Shuib, Azlin Ithnin, Hafiza Alauddin, Noor Farisah AR, Noraesah M, Tumian NR, Wong, CL, Raja Zahratul Azma Raja Sabudin
Format:	Article
Language:	English
Published:	Pusat Perubatan Universiti Kebangsaan Malaysia 2019
Online Access:	http://journalarticle.ukm.my/15220/ http://journalarticle.ukm.my/15220/1/12_ms0293_pdf_83778.pdf

Similar Items

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah, et al.
Published: (2012)

Aleukemic bcr-abl positive granulocytic sarcoma
by: Kuan, Jew-Win, et al.
Published: (2009)

Concomitant BCR-ABL and JAK2 V617F in a patient with myeloproliferative neoplasm: a case report
by: A, Alia Suzana, et al.
Published: (2023)

Detection of BCR/ABL gene in chronic Myeloid Leukaemia: comparison of Fluorescence in situ Hybridisation (FISH), conventional Cytogenetics and Polymerase Chain Reaction (PCR) techniques
by: Reena RMZ,, et al.
Published: (2006)

Genetic determinants excluding GBCR::ABL mutations of imatinib mesylate therapy response among chronic myeloid leukaemia patients in Malaysia
by: Ismail, Siti Mariam
Published: (2023)

Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
by: Razali, Ruzi Hamimi
Published: (2015)

Donor chimerism and bcr-abl gene status following non-myeloablative peripheral blood stem cell transplantation in chronic myeloid leukaemia patients in HUKM
by: Seman, Zainina, et al.
Published: (2008)

Molecular genetic and epigenetic mechanisms of primary and secondary resistance to imatinib mesylate treatment in ph chromosome positive chronic myeloid leukemia patients
by: Elias, Marjanu Hikmah
Published: (2015)

Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients
by: Chen, Li-Chia, et al.
Published: (2014)

Eccentricity of Acute Myeloid Leukemia with NPM1 and FLT3-ITD mutation: a case report
by: Nur Zainura Mohamad,, et al.
Published: (2022)

Ultra-high performance liquid chromatography (uhplc) method development and validation for the determination of serum imatinib and its active metabolite concentration among chronic myeloid leukemia patients
by: Liong, Tan Ka
Published: (2013)

Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML)
by: Phan CL,, et al.
Published: (2010)

Imbalanced expression of polycistronic miRNA in acute myeloid leukemia
by: Kotaki, Ryutaro, et al.
Published: (2017)

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia
by: Ley, T., et al.
Published: (2013)

Influence of tert gene expression, telomerase activity and telomere length in relation to imatinib mesylate resistance in Malaysian chronic myeloid leukaemia patients
by: Shamshudin, Wati @ Hayati Mohd
Published: (2020)

Clinical evaluation and proteomic profiles of acute myeloid leukemia patients, Saudi Arabia
by: Almaiman, Amer Abdulrahman
Published: (2015)

Gene aberrations and methylation analysis of JAK/stat and toll-like receptor downstream signalling in BCR-ABL-negative myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms overlap syndromes
by: Cai, Chia Yuh
Published: (2021)

Determination of gene copy number status in tert and terc among chronic myeloid leukaemia patients resist ant and responsive to imatinib mesylate treatment
by: Asrari, Zaidatul Shakila Mohamad
Published: (2014)

Proteomics profiling and genomics computational analysis of acute myeloid leukemia / Md. Mirazul Islam
by: Md. Mirazul, Islam
Published: (2017)

Analysis of Madm, a novel adaptor protein that associates with Myeloid Leukemia Factor 1
by: Lim, Raelene
Published: (2003)

Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells
by: Alharbi, Raed A., et al.
Published: (2017)

Detection of haemoglobin S using multiplex ligation-dependent probe amplification and flow-through hybridization techniques: experience in a tertiary hospital
by: Wee, SY, et al.
Published: (2020)

Targeted RNAi of the mitogen-activated protein kinase pathway genes in acute myeloid leukemia cells
by: Mohd Hafiz, M.R., et al.
Published: (2013)

Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.
by: Abdullah, Maha, et al.
Published: (2009)

Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)

Primary Bone Marrow Lymphoma with Secondary Central Nervous System Involvement: a case report
by: Hari Priya Raghyan,, et al.
Published: (2022)

Decitabine-Vorinostat combination treatment in acute myeloid leukemia activates pathways with potential for novel triple therapy
by: Young, Christine S., et al.
Published: (2017)

Cytotoxic Effects of Betulinic Acid and its Derivatives on Human Myeloid Leukemia (Hl-60) Cell Line
by: Faujan, Nur Hana
Published: (2008)

Molecular basis of primary and secondary resistance to imatinib mesylate
by: Abdul Aziz, Baba
Published: (2012)

Imatinab mesylate treatment in Chronic Myeloid Leukemia (CML)- understanding the fundamental pharmacokinetic and pharmacogenetic mechanisms for variation in response
by: Ankathil, Ravindran
Published: (2016)

Influence of ORM1, PXR, CAR, CYP3A4 and CYP3A5 gene polymorphisms in mediating susceptibility risk to chronic myeloid leukaemia and response to imatinib mesylate therapy
by: Maddin, Najlaa
Published: (2017)

Gene Expression, Biochemical And Functional Analysis Of Stromal Interaction Molecule 1 (Stim1) Silencing In Acute Myeloid Leukemia Cell Lines
by: Algariri, Eman Salem Saeed
Published: (2022)

Towards Response-Able Mathematics Education.
by: Atweh, Bill
Published: (2008)

Recognised the abilities of differently-abled persons
by: Abd Razak, Dzulkifli
Published: (2004)

Lysine specific demethylase 1 inactivation enhances differentiation and promotes cytotoxic response when combined with all-trans retinoic acid in acute myeloid leukemia across subtypes
by: Smitheman, K.N., et al.
Published: (2019)

Effects of epigallocatechin-3-gallate (EGCG) on cell cycle distribution and DNA integrity of K562 cells, a human chronic myeloid leukemia
by: Elda Surhaida Latif,, et al.
Published: (2020)

Cytotoxic effect of betulinic acid and betulinic acid acetate isolated from Melaleuca cajuput on human myeloid leukemia (HL-60) cell line
by: Faujan, Nur Hana, et al.
Published: (2010)

Application of high resolution melting (HRM) analysis in detection of PDGFRA gene mutations among chronic myeloid leukemia patients treated with imanitib mesylate
by: Rashid, Nur Sabrina Abd
Published: (2020)

Survival analysis in acute myeloid leukemia: A retrospective cohort study and simulation study of small events per independent variable / Law Kian Boon
by: Law , Kian Boon
Published: (2017)

Biphenotypic acute leukemia: a report of two cases
by: RZ Azma,, et al.
Published: (2006)